Myriad Genetics Inc (MYGN)

Total asset turnover

Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Revenue (ttm) US$ in thousands 817,300 794,900 766,400 745,400 731,500 696,200 691,900 675,200 820,600 831,200 839,900 846,300 666,200 590,100 564,400 586,600 627,900 750,000 801,700 822,500
Total assets US$ in thousands 1,081,300 1,085,100 1,110,500 1,146,500 1,149,100 1,187,200 1,169,300 1,198,700 1,212,000 1,210,200 1,255,400 1,320,700 1,335,900 1,360,300 1,336,900 1,444,500 1,404,600 1,446,700 1,578,300 1,591,200
Total asset turnover 0.76 0.73 0.69 0.65 0.64 0.59 0.59 0.56 0.68 0.69 0.67 0.64 0.50 0.43 0.42 0.41 0.45 0.52 0.51 0.52

September 30, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $817,300K ÷ $1,081,300K
= 0.76

Myriad Genetics Inc's total asset turnover has shown fluctuations over the past few quarters. The ratio indicates how efficiently the company is generating revenue from its assets.

From September 2019 to September 2020, the total asset turnover ratio increased gradually from 0.45 to 0.68 before declining slightly in the following quarters. However, the overall trend shows an improvement in asset utilization efficiency, reaching a high of 0.76 in September 2024.

The increase in total asset turnover suggests that Myriad Genetics Inc has been more successful in generating sales from its assets, which is positive for the company's financial performance. It indicates that management is effectively utilizing its assets to generate revenue.

The fluctuations in the ratio may be influenced by various factors such as changes in revenue, asset efficiency, or changes in the composition of the asset base. Investors and analysts should continue to monitor the total asset turnover ratio along with other financial metrics to assess the company's operational efficiency and overall financial health.


Peer comparison

Sep 30, 2024